SEC Form 4 · accession 0001209191-17-021246
Corbus Pharmaceuticals Holdings, Inc. · CRBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yuval Cohen
Officer — Chief Executive Officer · Director
Period of report
Mar 16, 2017
Accepted (ET)
Mar 17, 2017 · 7:58 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 16, 2017 | M | 20,000 | $1.00 | A | 52,830 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stock | $1.00 | Mar 16, 2017 | M | 20,000 | D | Apr 11, 2015 | Apr 11, 2024 | Common stock | 20,000 | 272,728 | D |